PolarityTE Announces Submission of Complete Response to FDA's Clinical Hold Correspondence for SkinTE® Investigational New Drug Application

Stock Information for PolarityTE Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PolarityTE Inc.

Pioneering Technology Reports 2023 Q2 Financial Results
Pioneering Technology Corp. Announces Senior Management Appointment and Issuance of New Options
Pioneering Technology Reports 2023 Q1 Financial Results
Pioneering Technology Reports Fiscal Year 2022 Financial Results
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company
PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.